Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments

Trisomy 21 or Down syndrome (DS) is a complex syndrome, of genetic origin with multiple and variable neurobiological and neuropsychological manifestations. DS patients have consistent signs of brain damage along their lives, but understanding the biology of DS is complicated due to the extraordinary...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Behavior genetics 2006-05, Vol.36 (3), p.454-468
Hauptverfasser: Dierssen, Mara, Ortiz-Abalia, Jon, Arqué, Glòria, de Lagrán, María Martínez, Fillat, Cristina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 468
container_issue 3
container_start_page 454
container_title Behavior genetics
container_volume 36
creator Dierssen, Mara
Ortiz-Abalia, Jon
Arqué, Glòria
de Lagrán, María Martínez
Fillat, Cristina
description Trisomy 21 or Down syndrome (DS) is a complex syndrome, of genetic origin with multiple and variable neurobiological and neuropsychological manifestations. DS patients have consistent signs of brain damage along their lives, but understanding the biology of DS is complicated due to the extraordinary heterogeneity of the phenotypic signs. Thus, treatment of DS mental retardation poses significant challenges for clinicians and scientists. The review addresses the classical pharmacological and environmental treatments and also critically reviews the new possibilities that are emerging from the exciting advances in gene or cell therapy. We describe some of the most recent developments in the field and give a sense of the prospects for future prevention and therapy.
doi_str_mv 10.1007/s10519-006-9050-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68051332</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57222476</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-ac07d41b762d3e503b5e25b90b02f8e3545aa5ddc0321a9cda7c739c2a926ff33</originalsourceid><addsrcrecordid>eNqFkUuLFDEQgIMo7rj6A7xIUPDWWqm8Jt5kfcKCHvQc0km108v0w6Rb2X9vmhkQBNlTUdRXVal8jD0V8EoA2NdFgBauATCNAw0N3mM7oa1sJDp7n-0AQDR7VOqCPSrlpqZolH7ILoTRCLVlx3587ZcuHI-FhzHxwzRT4f3I302_R15ux5SngfhyoBxmWpc-8jDPeQrxQOXNBtYSLxRyPPBuypx-9YnGSE0bCiW-ZArLQONSHrMHdU2hJ-d4yb5_eP_t6lNz_eXj56u3101UwixNiGCTEq01mCRpkK0m1K2DFrDbk9RKh6BTiiBRBBdTsNFKFzE4NF0n5SV7eZpbX_lzpbL4oS-Rjscw0rQWb_b1y6TEO0FtEVFZcyconHLWqQ188Q94M615rNd6NEZhVaZ1pZ7_l0IHQllrKyROUMxTKZk6P-d-CPnWC_Cben9S76t6v6n320HPzoPXdqD0t-PsWv4BF9KodQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229014777</pqid></control><display><type>article</type><title>Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><creator>Dierssen, Mara ; Ortiz-Abalia, Jon ; Arqué, Glòria ; de Lagrán, María Martínez ; Fillat, Cristina</creator><creatorcontrib>Dierssen, Mara ; Ortiz-Abalia, Jon ; Arqué, Glòria ; de Lagrán, María Martínez ; Fillat, Cristina</creatorcontrib><description>Trisomy 21 or Down syndrome (DS) is a complex syndrome, of genetic origin with multiple and variable neurobiological and neuropsychological manifestations. DS patients have consistent signs of brain damage along their lives, but understanding the biology of DS is complicated due to the extraordinary heterogeneity of the phenotypic signs. Thus, treatment of DS mental retardation poses significant challenges for clinicians and scientists. The review addresses the classical pharmacological and environmental treatments and also critically reviews the new possibilities that are emerging from the exciting advances in gene or cell therapy. We describe some of the most recent developments in the field and give a sense of the prospects for future prevention and therapy.</description><identifier>ISSN: 0001-8244</identifier><identifier>EISSN: 1573-3297</identifier><identifier>DOI: 10.1007/s10519-006-9050-2</identifier><identifier>PMID: 16520905</identifier><identifier>CODEN: BHGHAT</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Adults ; Aggressiveness ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Biology ; Biomedical research ; Brain - pathology ; Brain damage ; Brain injury ; Brain research ; Cell therapy ; Cognitive therapy ; Disease Models, Animal ; Down syndrome ; Down Syndrome - drug therapy ; Down Syndrome - genetics ; Down Syndrome - therapy ; Down's syndrome ; Downs syndrome ; Evidence based research ; Evidence-based medicine ; Evidence-Based Medicine - methods ; Evidence-Based Medicine - trends ; Genes ; Humans ; Infant ; Intellectual disabilities ; Mice ; N-Methylaspartate - physiology ; Newborn babies ; Phenotype ; Prospects ; Research parks ; Therapeutic approaches ; Treatment methods ; Trisomy ; Trisomy 21</subject><ispartof>Behavior genetics, 2006-05, Vol.36 (3), p.454-468</ispartof><rights>Springer Science+Business Media, Inc. 2006</rights><rights>Springer Science+Business Media, Inc. 2006.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-ac07d41b762d3e503b5e25b90b02f8e3545aa5ddc0321a9cda7c739c2a926ff33</citedby><cites>FETCH-LOGICAL-c416t-ac07d41b762d3e503b5e25b90b02f8e3545aa5ddc0321a9cda7c739c2a926ff33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,12846,27924,27925,30999,31000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16520905$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dierssen, Mara</creatorcontrib><creatorcontrib>Ortiz-Abalia, Jon</creatorcontrib><creatorcontrib>Arqué, Glòria</creatorcontrib><creatorcontrib>de Lagrán, María Martínez</creatorcontrib><creatorcontrib>Fillat, Cristina</creatorcontrib><title>Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments</title><title>Behavior genetics</title><addtitle>Behav Genet</addtitle><description>Trisomy 21 or Down syndrome (DS) is a complex syndrome, of genetic origin with multiple and variable neurobiological and neuropsychological manifestations. DS patients have consistent signs of brain damage along their lives, but understanding the biology of DS is complicated due to the extraordinary heterogeneity of the phenotypic signs. Thus, treatment of DS mental retardation poses significant challenges for clinicians and scientists. The review addresses the classical pharmacological and environmental treatments and also critically reviews the new possibilities that are emerging from the exciting advances in gene or cell therapy. We describe some of the most recent developments in the field and give a sense of the prospects for future prevention and therapy.</description><subject>Adults</subject><subject>Aggressiveness</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Biology</subject><subject>Biomedical research</subject><subject>Brain - pathology</subject><subject>Brain damage</subject><subject>Brain injury</subject><subject>Brain research</subject><subject>Cell therapy</subject><subject>Cognitive therapy</subject><subject>Disease Models, Animal</subject><subject>Down syndrome</subject><subject>Down Syndrome - drug therapy</subject><subject>Down Syndrome - genetics</subject><subject>Down Syndrome - therapy</subject><subject>Down's syndrome</subject><subject>Downs syndrome</subject><subject>Evidence based research</subject><subject>Evidence-based medicine</subject><subject>Evidence-Based Medicine - methods</subject><subject>Evidence-Based Medicine - trends</subject><subject>Genes</subject><subject>Humans</subject><subject>Infant</subject><subject>Intellectual disabilities</subject><subject>Mice</subject><subject>N-Methylaspartate - physiology</subject><subject>Newborn babies</subject><subject>Phenotype</subject><subject>Prospects</subject><subject>Research parks</subject><subject>Therapeutic approaches</subject><subject>Treatment methods</subject><subject>Trisomy</subject><subject>Trisomy 21</subject><issn>0001-8244</issn><issn>1573-3297</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUuLFDEQgIMo7rj6A7xIUPDWWqm8Jt5kfcKCHvQc0km108v0w6Rb2X9vmhkQBNlTUdRXVal8jD0V8EoA2NdFgBauATCNAw0N3mM7oa1sJDp7n-0AQDR7VOqCPSrlpqZolH7ILoTRCLVlx3587ZcuHI-FhzHxwzRT4f3I302_R15ux5SngfhyoBxmWpc-8jDPeQrxQOXNBtYSLxRyPPBuypx-9YnGSE0bCiW-ZArLQONSHrMHdU2hJ-d4yb5_eP_t6lNz_eXj56u3101UwixNiGCTEq01mCRpkK0m1K2DFrDbk9RKh6BTiiBRBBdTsNFKFzE4NF0n5SV7eZpbX_lzpbL4oS-Rjscw0rQWb_b1y6TEO0FtEVFZcyconHLWqQ188Q94M615rNd6NEZhVaZ1pZ7_l0IHQllrKyROUMxTKZk6P-d-CPnWC_Cben9S76t6v6n320HPzoPXdqD0t-PsWv4BF9KodQ</recordid><startdate>200605</startdate><enddate>200605</enddate><creator>Dierssen, Mara</creator><creator>Ortiz-Abalia, Jon</creator><creator>Arqué, Glòria</creator><creator>de Lagrán, María Martínez</creator><creator>Fillat, Cristina</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QG</scope><scope>7QJ</scope><scope>7SS</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200605</creationdate><title>Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments</title><author>Dierssen, Mara ; Ortiz-Abalia, Jon ; Arqué, Glòria ; de Lagrán, María Martínez ; Fillat, Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-ac07d41b762d3e503b5e25b90b02f8e3545aa5ddc0321a9cda7c739c2a926ff33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adults</topic><topic>Aggressiveness</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Biology</topic><topic>Biomedical research</topic><topic>Brain - pathology</topic><topic>Brain damage</topic><topic>Brain injury</topic><topic>Brain research</topic><topic>Cell therapy</topic><topic>Cognitive therapy</topic><topic>Disease Models, Animal</topic><topic>Down syndrome</topic><topic>Down Syndrome - drug therapy</topic><topic>Down Syndrome - genetics</topic><topic>Down Syndrome - therapy</topic><topic>Down's syndrome</topic><topic>Downs syndrome</topic><topic>Evidence based research</topic><topic>Evidence-based medicine</topic><topic>Evidence-Based Medicine - methods</topic><topic>Evidence-Based Medicine - trends</topic><topic>Genes</topic><topic>Humans</topic><topic>Infant</topic><topic>Intellectual disabilities</topic><topic>Mice</topic><topic>N-Methylaspartate - physiology</topic><topic>Newborn babies</topic><topic>Phenotype</topic><topic>Prospects</topic><topic>Research parks</topic><topic>Therapeutic approaches</topic><topic>Treatment methods</topic><topic>Trisomy</topic><topic>Trisomy 21</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dierssen, Mara</creatorcontrib><creatorcontrib>Ortiz-Abalia, Jon</creatorcontrib><creatorcontrib>Arqué, Glòria</creatorcontrib><creatorcontrib>de Lagrán, María Martínez</creatorcontrib><creatorcontrib>Fillat, Cristina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Sociology Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Sociology Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Behavior genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dierssen, Mara</au><au>Ortiz-Abalia, Jon</au><au>Arqué, Glòria</au><au>de Lagrán, María Martínez</au><au>Fillat, Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments</atitle><jtitle>Behavior genetics</jtitle><addtitle>Behav Genet</addtitle><date>2006-05</date><risdate>2006</risdate><volume>36</volume><issue>3</issue><spage>454</spage><epage>468</epage><pages>454-468</pages><issn>0001-8244</issn><eissn>1573-3297</eissn><coden>BHGHAT</coden><abstract>Trisomy 21 or Down syndrome (DS) is a complex syndrome, of genetic origin with multiple and variable neurobiological and neuropsychological manifestations. DS patients have consistent signs of brain damage along their lives, but understanding the biology of DS is complicated due to the extraordinary heterogeneity of the phenotypic signs. Thus, treatment of DS mental retardation poses significant challenges for clinicians and scientists. The review addresses the classical pharmacological and environmental treatments and also critically reviews the new possibilities that are emerging from the exciting advances in gene or cell therapy. We describe some of the most recent developments in the field and give a sense of the prospects for future prevention and therapy.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>16520905</pmid><doi>10.1007/s10519-006-9050-2</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-8244
ispartof Behavior genetics, 2006-05, Vol.36 (3), p.454-468
issn 0001-8244
1573-3297
language eng
recordid cdi_proquest_miscellaneous_68051332
source MEDLINE; SpringerLink Journals; Applied Social Sciences Index & Abstracts (ASSIA)
subjects Adults
Aggressiveness
Animals
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Biology
Biomedical research
Brain - pathology
Brain damage
Brain injury
Brain research
Cell therapy
Cognitive therapy
Disease Models, Animal
Down syndrome
Down Syndrome - drug therapy
Down Syndrome - genetics
Down Syndrome - therapy
Down's syndrome
Downs syndrome
Evidence based research
Evidence-based medicine
Evidence-Based Medicine - methods
Evidence-Based Medicine - trends
Genes
Humans
Infant
Intellectual disabilities
Mice
N-Methylaspartate - physiology
Newborn babies
Phenotype
Prospects
Research parks
Therapeutic approaches
Treatment methods
Trisomy
Trisomy 21
title Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A15%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pitfalls%20and%20hopes%20in%20Down%20syndrome%20therapeutic%20approaches:%20in%20the%20search%20for%20evidence-based%20treatments&rft.jtitle=Behavior%20genetics&rft.au=Dierssen,%20Mara&rft.date=2006-05&rft.volume=36&rft.issue=3&rft.spage=454&rft.epage=468&rft.pages=454-468&rft.issn=0001-8244&rft.eissn=1573-3297&rft.coden=BHGHAT&rft_id=info:doi/10.1007/s10519-006-9050-2&rft_dat=%3Cproquest_cross%3E57222476%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229014777&rft_id=info:pmid/16520905&rfr_iscdi=true